Icure Pharmaceutical Incorporation (175250) — Capital Reinvestment Ratio
Icure Pharmaceutical Incorporation (175250) has a Capital Reinvestment Ratio of 38.07x as of June 2020, meaning it reinvests 38% of its operating cash flow (₩195.44 Million) in capital expenditures (₩7.44 Billion). See Icure Pharmaceutical Incorporation (175250) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Icure Pharmaceutical Incorporation Capital Reinvestment Ratio (2017–2017)
This chart tracks Icure Pharmaceutical Incorporation's Capital Reinvestment Ratio across 1 annual periods. Check 175250 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Icure Pharmaceutical Incorporation (2017–2017)
Year-by-year Capital Reinvestment Ratio for Icure Pharmaceutical Incorporation from 2017 to 2017. For live market cap and broader valuation context, see Icure Pharmaceutical Incorporation market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 9.02x | ₩1.12 Billion | ₩10.10 Billion | — |